STX4
Basic information
Region (hg38): 16:31032889-31042975
Previous symbols: [ "STX4A" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Deafness, autosomal recessive 123 | AR | Audiologic/Otolaryngologic | As some presentations may involve prelingual hearing loss, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic | 36355422 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (21 variants)
- not_provided (1 variants)
- Sensorineural_hearing_loss_disorder (1 variants)
- Hearing_loss,_autosomal_recessive_123 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STX4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004604.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 21 | 2 | 23 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 26 | 2 | 0 |
Highest pathogenic variant AF is 0.0000020523457
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| STX4 | protein_coding | protein_coding | ENST00000313843 | 10 | 10087 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.30e-7 | 0.599 | 125703 | 0 | 45 | 125748 | 0.000179 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.11 | 135 | 176 | 0.765 | 0.0000107 | 1947 |
| Missense in Polyphen | 38 | 57.412 | 0.66189 | 632 | ||
| Synonymous | 0.159 | 72 | 73.7 | 0.976 | 0.00000473 | 556 |
| Loss of Function | 1.06 | 13 | 17.9 | 0.728 | 8.25e-7 | 211 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000245 | 0.000181 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.000168 | 0.000163 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.000301 | 0.000299 |
| Middle Eastern | 0.000168 | 0.000163 |
| South Asian | 0.0000660 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plasma membrane t-SNARE that mediates docking of transport vesicles. Necessary for the translocation of SLC2A4 from intracellular vesicles to the plasma membrane. Together with STXB3 and VAMP2, may also play a role in docking/fusion of intracellular GLUT4-containing vesicles with the cell surface in adipocytes (By similarity). May also play a role in docking of synaptic vesicles at presynaptic active zones. {ECO:0000250}.;
- Pathway
- Vasopressin-regulated water reabsorption - Homo sapiens (human);SNARE interactions in vesicular transport - Homo sapiens (human);Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics;Insulin Signaling;Clathrin derived vesicle budding;trans-Golgi Network Vesicle Budding;Other interleukin signaling;Signaling by Interleukins;Vesicle-mediated transport;Membrane Trafficking;Cytokine Signaling in Immune system;Immune System;Adaptive Immune System;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Disinhibition of SNARE formation;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;EGFR1;Hemostasis;ER-Phagosome pathway;Stabilization and expansion of the E-cadherin adherens junction;Insulin-mediated glucose transport
(Consensus)
Intolerance Scores
- loftool
- 0.705
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.44
Haploinsufficiency Scores
- pHI
- 0.0983
- hipred
- Y
- hipred_score
- 0.550
- ghis
- 0.584
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.936
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stx4a
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- intracellular protein transport;exocytosis;vesicle fusion;positive regulation of cell population proliferation;regulation of exocytosis;cytokine-mediated signaling pathway;positive regulation of cell migration;synaptic vesicle fusion to presynaptic active zone membrane;response to hydroperoxide;SNARE complex assembly;positive regulation of insulin secretion involved in cellular response to glucose stimulus;positive regulation of catalytic activity;positive regulation of eosinophil degranulation;positive regulation of cell adhesion;vesicle docking;organelle fusion;positive regulation of chemotaxis;positive regulation of immunoglobulin secretion;long-term synaptic potentiation;cellular response to interferon-gamma;regulation of extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of protein localization to plasma membrane;vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;positive regulation of protein localization to cell surface
- Cellular component
- storage vacuole;extracellular space;endosome;vacuole;trans-Golgi network;cytosol;plasma membrane;synaptic vesicle;cell surface;endomembrane system;membrane;integral component of membrane;basolateral plasma membrane;lamellipodium;phagocytic vesicle membrane;SNARE complex;myelin sheath adaxonal region;somatodendritic compartment;specific granule;presynaptic membrane;dendritic spine;lateral loop;synapse;perinuclear region of cytoplasm;presynaptic active zone membrane;extracellular exosome;postsynapse;glutamatergic synapse
- Molecular function
- SNARE binding;SNAP receptor activity;protein binding;sphingomyelin phosphodiesterase activator activity